Nephro-Urology Monthly

Published by: Kowsar

Efficacy of Anti-Interleukin-2 Receptor Antibody in Reducing the Incidence of Acute Rejection After Renal Transplantation

Alexandre Liborio 1 , * and Tacyano Leite 2
Authors Information
1 University of Fortaleza – UNIFOR, Fortaleza, Brazil
2 Hospital Geral de Fortaleza, Fortaleza, Brazil
Article information
  • Nephro-Urology Monthly: September 01, 2012, 4 (4); 650-651
  • Published Online: September 24, 2012
  • Article Type: Letter
  • Received: July 11, 2012
  • Revised: July 19, 2012
  • Accepted: July 21, 2012
  • DOI: 10.5812/numonthly.7279

To Cite: Liborio A, Leite T. Efficacy of Anti-Interleukin-2 Receptor Antibody in Reducing the Incidence of Acute Rejection After Renal Transplantation, Nephro-Urol Mon. 2012 ; 4(4):650-651. doi: 10.5812/numonthly.7279.

Copyright © 2012, Nephrology and Urology Research Center. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
Footnotes
References
  • 1. Sageshima J, Ciancio G, Chen L, Burke GW, 3rd. Anti-interleukin-2 receptor antibodies-basiliximab and daclizumab-for the prevention of acute rejection in renal transplantation. Biologics. 2009; 3: 319-36[PubMed]
  • 2. Brennan DC, Daller JA, Lake KD, Cibrik D, Del Castillo D. Rabbit antithymocyte globulin versus basiliximab in renal transplantation. N Engl J Med. 2006; 355(19): 1967-77[DOI][PubMed]
  • 3. Saghafi H, Rahbar K, Qoreishi M, Safdari F. Efficacy of Anti-Interleukin-2 Receptor Antibody (Daclizumab) in Reducing the Incidence of Acute Rejection After Renal Transplantation. Nephro-Urol Mon. 2012; 4(2): 475-7[DOI]
  • 4. Vincenti F, Kirkman R, Light S, Bumgardner G, Pescovitz M, Halloran P, et al. Interleukin-2-receptor blockade with daclizumab to prevent acute rejection in renal transplantation. Daclizumab Triple Therapy Study Group. N Engl J Med. 1998; 338(3): 161-5[DOI][PubMed]
  • 5. Ekberg H, Tedesco-Silva H, Demirbas A, Vitko S, Nashan B, Gurkan A, et al. Reduced exposure to calcineurin inhibitors in renal transplantation. N Engl J Med. 2007; 357(25): 2562-75[DOI][PubMed]
Readers' Comments